December 15th, 2015

Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Biogen wins protection for MS drug Tecfidera in Europe

[Reuters] – Biogen Idec has won regulatory protection for its top-selling multiple sclerosis drug Tecfidera in Europe, paving the way for its launch in markets that could account for a large proportion of . . . → Read More: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Biogen wins protection for MS drug Tecfidera in Europe Similar posts: TI introduces first single-chip battery gauge with integrated protection – Texas Instruments Incorporated (NASDAQ:TXN) Why trust Paulson and Bernanke to run an insurance company Russia vs. the Ukraine: Gazprom always wins

Biogen Idec Inc. (NASDAQ:BIIB) [Reuters] – Biogen Idec has won regulatory protection for its top-selling multiple sclerosis drug Tecfidera in Europe, paving the way for its launch in markets that could account for a large proportion of future sales. The European Medicines Agency said on Friday it had granted the oral medicine a “new active substance” (NAS) designation, securing Biogen 10 years protection through data exclusivity that will stop generic firms from launching copycat versions. In March, … [visit site to read more]

Similar posts:
  1. TI introduces first single-chip battery gauge with integrated protection – Texas Instruments Incorporated (NASDAQ:TXN)
  2. Why trust Paulson and Bernanke to run an insurance company
  3. Russia vs. the Ukraine: Gazprom always wins
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.